Fabio Palombo
Chief scientific officer
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Fabio Palombo is the Chief Scientific Officer at Neomatrix Biotech in Italy. His research primarily focuses on vaccine development, particularly related to COVID-19 and cancer immunotherapy. Recent articles explore the immunogenicity and efficacy of novel DNA vaccines delivered via electroporation, alongside investigations into the influence of microbiota on vaccine responses. Palombo's work contributes significantly to understanding and improving vaccination strategies against viral infections and cancer.
Articles (8)
Year:
2023
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (5)
Luigi Aurisicchio
Chief Executive Officer
-
Giuseppe Roscilli
Chief Technology Officer and Director
-
Kathryn Ann Ryan
UK Health Security Agency
Luca G. Guidotti
Full Professor
Università Vita Salute San Raffaele
Raffaele De Francesco
Professore Ordinario di Microbiologia (BIO/19)
Università degli Studi di Torino
Make your next move.
Prepare your application
Review drafts before you send them.